Cameroon vs Georgia: Treatment success rate for patients treated for MDR-TB
Cameroon
82.0%
in 2022
Georgia
81.0%
in 2022
Cameroon rank
44th
Georgia rank
46th
Treatment success rate for patients treated for MDR-TB over time
- Cameroon
- Georgia
How they compare
Cameroon currently reports 82.0% against 81.0% in Georgia, a difference of 1.0%.
The two have swapped places 4 times across 16 shared years of data; in 2007 it was Cameroon ahead.
Cameroon ranks 44th and Georgia ranks 46th of 163 countries.
Cameroon has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Cameroon | Georgia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 89.7% | 49.3% | 40.3% | Cameroon |
| 2010s | 78.1% | 57.4% | 20.7% | Cameroon |
| 2020s | 79.7% | 77.7% | 2.0% | Cameroon |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Cameroon or Georgia?
- Cameroon, at 82.0% against 81.0% in Georgia as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Cameroon and Georgia?
- 1.0%, with Cameroon ahead.
- How many years of comparable data are there for Cameroon and Georgia?
- 16 years are reported by both, from 2007 to 2022.
- How do Cameroon and Georgia rank globally for treatment success rate for patients treated for mdr-tb?
- Cameroon ranks 44th and Georgia ranks 46th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.